Yong Yang

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Zhenggang Ren, Jianming Xu, Yuxian Bai et al. · The Lancet Oncology · 2021 · 1K citations

Hepatology, Bevacizumab Biosimilar, Medicine +8

Anterior controllable antidisplacement and fusion surgery for the treatment of multilevel severe ossification of the posterior longitudinal ligament with myelopathy: preliminary clinical results of a novel technique

Jingchuan Sun, Jiangang Shi, Ximing Xu et al. · European Spine Journal · 2017 · 72 citations · Full text

Electrochemical Impedance Spectroscopic Detection of <i>E.coli</i> with Machine Learning

Ying Xu, Chao Li, Yang Jiang et al. · Journal of The Electrochemical Society · 2020 · 43 citations

Engineering, Machine Learning, Biosensing Systems +13

CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population

Bin Li, Xiaoying Chen, Yuting Jiang et al. · Immunology Letters · 2017 · 42 citations

Autoimmune Disease, Genetics, Gouty Arthritis +5

Anterior Controllable Antedisplacement Fusion (ACAF) for Severe Cervical Ossification of the Posterior Longitudinal Ligament: Comparison with Anterior Cervical Corpectomy with Fusion (ACCF)

Haisong Yang, Jingchuan Sun, Jiangang Shi et al. · World Neurosurgery · 2018 · 40 citations

Spinal Cord Injury, Medicine, Spinal Fusion +8